Non-Small Cell Lung Cancer (NSCLC) accounts for 80–85% of all lung cancer diagnoses and poses challenges in early detection due to symptoms often resembling common illnesses or long-term smoking effects.
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
